Global 3D bioprinting market is
expected to reach USD 1.82 billion by 2022, according to a new report by Grand
View Research Inc. Rising prevalence of chronic diseases such as Chronic Kidney
Disease (CKD) which demands kidney transplantation is expected to boost the
market growth, as 3D bioprinting is convenient and cost effective substitute
for organ transplantation.
Emerging medical applications
of 3D bioprinting such as toxicity testing, drug discovery, tissue engineering
and consumer product testing are expected to further drive the market growth
positively. Increasing R&D expenditure is anticipated to be high impact
rendering driver for the industry. 3D bioprinting advances in tissue
engineering and allows developments to be done using biomaterials which have
better biocompatibility. Moreover, rising geriatric population is expected to
assist the market growth, as this demographic is highly susceptible to age
related organ deformities.
In depth research report on 3D Bioprinting Market
Further key findings from the study suggest:
·
Syringe based printers
dominated the technology segment as these printers allow working in sterile
environment. Moreover, syringe based printers have wide applications which
include fabrication of scaffolds, cell strips printing, and tissue printing.
·
Magnetic levitation based
printers are expected to witness lucrative growth over the forecast period.
This can be attributed to emerging medical applications such as screening of
cardiovascular toxicity, human cell modeling and smooth muscle printing.
·
The medical applications
segment is expected to gain substantial share of over 32.0% by 2022 which can
be attributed to emerging applications of 3D bioprinting such as toxicity
screening, organ transplants and medical pills.
·
Dental application segment is
expected to witness lucrative growth over the forecast period. Rising demand
for cosmetic dentistry along with growing awareness about oral hygiene are
expected to foster the demand for dental applications.
·
North America dominated the
regional 3D bioprinting market with over 35.0% share and is expected to grow at
a CAGR of 10.0%. Supportive government initiatives to improve healthcare
infrastructure coupled with growing disposable income are vital driving factor
for this region’s growth.
·
Asia Pacific is expected to
witness lucrative growth over the forecast period. Favorable government support
to improve healthcare delivery with economic developments in emerging countries
such as India and China are expected to increase the demand for 3D bioprinting.
·
Key players operating in the 3D
bioprinting industry include Organovo Holding Inc., Cyfuse Biomedical, BioBots,
Luxexcel Group BV, TeVido BioDevices, Aspect Biosystems, 3Dynamics Systems,
Stratasys Ltd., Voxeljet, Oceanz, Materialise NV, Envision TEC, Bio3D
Technologies, Solidscape and others.
·
These players are involved in
various strategic initiatives such as new product launches, strategic alliances
and mergers and acquisitions to gain the edge over the competitors. For
instance, In June 2015, Orgonovo collaborated with L’Oreal to develop skin
tissue using NovoGen Bioprinting platform.
Grand View Research has
segmented the global 3D bioprinting market on the basis of products and region:
3D
Bioprinting Market Technology Outlook (USD million), 2012 - 2022
·
Magnetic levitation
·
Inkjet based
·
Syringe based
·
Laser based
·
Other
3D Bioprinting Market Application Outlook (USD million),
2012 - 2022
·
Medical
o
Tissue and organ generation
o
Medical pills
o
Prosthetics and implants
·
Dental
·
Biosensors
·
Consumer/Personal products
testing
·
Bioinks
·
Food and animal product
bioprinting
3D Bioprinting Market Regional Outlook (USD million), 2012
- 2022
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
·
MEA
o
South Africa
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment